Perry Renshaw

Academic / Other · 7 registered clinical trials.

Status	Trial	Phase	Started
Completed	5-hydroxytryptophan and Creatine for Treatment Resistant Depression Associated With Hypoxia in Females Major Depressive Disorder	Phase 4	2015-04-01
Completed	Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive Disorder Major Depressive Disorder	Phase 4	2014-11-21
Completed	A Randomized Double-Blind Controlled Trial of Creatine in Female Methamphetamine Users Depression, Dual Diagnosis, Drug Addiction	Phase 4	2014-09-01
Completed	Creatine as a Treatment Option for Depression in Methamphetamine Using Females Depression, Substance Abuse, Substance Use	Phase 4	2013-01-01
Completed	Dose-Ranging Trial of Creatine Augmentation for Adolescent Females With Treatment-Resistant Major Depressive D Major Depressive Disorder	EARLY_Phase 1	2012-06-01
Terminated	Open-Label Creatine Study for Female Meth Users Depression, Dual Diagnosis, Substance Use	N/A	2012-01-01
Completed	Citicoline Treatment of Methamphetamine Dependence Methamphetamine Dependence	Phase 3	2010-01-01